Impact of FAB Classification on Predicting Outcome in Acute Myeloid Leukemia, Not Otherwise Specified, Patients Undergoing Allogeneic Stem Cell Transplantation in CR1: An Analysis of 1690 Patients From the Acute Leukemia Working Party of EBMT

American Journal of Hematology - United States
doi 10.1002/ajh.24640
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Related search

Allogeneic Stem Cell Transplantation Following Relapse Post Autologous Stem Cell Transplantation in Adult Patients With Acute Myeloid Leukemia: A Retrospective Analysis of 537 Patients From the Acute Leukemia Working Party of the EBMT

American Journal of Hematology
Hematology
2018English

Allogeneic Hematopoietic Stem Cell Transplantation for Secondary Acute Myeloid Leukemia- A Report From the Acute Leukemia Working Party of the EBMT

Biology of Blood and Marrow Transplantation
TransplantationHematology
2016English

Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Acute Myeloid Leukemia Over 70 Years of Age: On Behalf of the Acute Leukemia Working Party of the EBMT

Biology of Blood and Marrow Transplantation
TransplantationHematology
2018English

Higher Doses of Antithymocyte Globulin (ATG) Increase the Risk of Relapse in Acute Myeloid Leukemia (AML) Patients Undergoing Matched Related Donor Allogeneic Transplantation in First Complete Remission (CR1): An Analysis From the Acute Leukemia Working Party of EBMT

Blood
BiochemistryImmunologyCell BiologyHematology
2014English

Clofarabine Does Not Negatively Impact the Outcomes of Patients With Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2013English

Allogeneic Stem Cell Transplantation for T(3;3)(q21;q26)/Inv(3)(q21;q26) Acute Myeloid Leukemia – Report From the Acute Leukemia Working Party of the EBMT

Biology of Blood and Marrow Transplantation
TransplantationHematology
2016English

Defining the Prognostic Implications of Recurring Cytogenetic Aberrations and FLT3-ITD in Acute Myeloid Leukemia Patients Undergoing Allogeneic Stem Cell Transplantation: On Behalf of the ALWP of the EBMT

Biology of Blood and Marrow Transplantation
TransplantationHematology
2019English

Measurable Residual Disease, Conditioning Regimen Intensity and Age Predict Outcome of Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia in First Remission: A Registry Analysis of 2292 Patients by the Acute Leukemia Working Party Eu

American Journal of Hematology
Hematology
2018English

Inferior Outcome of Allogeneic Stem Cell Transplantation for Secondary Acute Myeloid Leukemia in First Complete Remission as Compared to De Novo Acute Myeloid Leukemia

Blood Cancer Journal
OncologyHematology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy